KLOW Protocol for Skincare The KLOW protocol used a fixed dose of 1.6-4.8 mg and is split up into three phases: activation (weeks 14), remodeling (weeks 58), and maintenance (weeks 912), followed by 48 weeks off
The $300 peptide problem The economics of peptide research create a paradox
Pregnant or nursing mothers, or individuals with a known medical condition, should not use or experiment with this product
What is biologically interesting is not yet clinically justified In medicine, "biologically interesting" and "clinically justified" are not the same statement
Analysis of clinical features, diagnostic tests, and biomarkers in patients with suspected Creutzfeldt-Jakob disease, 2014-2021
After 28 days, the solution should be discarded and a fresh vial reconstituted if ongoing research requires it